Expergen Pharmaceuticals Private Limited

Expergen Pharmaceuticals Private Limited - trading in Andheri East Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74120MH2011PTC213351 Incorporated 12 February 2011 ROC Mumbai HQ Andheri East Mumbai, Maharashtra, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2020
₹63,630
▲ 10% YoY
Net profit · FY 2020
₹454
Net margin 0.7%
EBITDA · FY 2020
₹613
EBITDA margin 1%
Authorised capital
₹14 Lakh
Registered with MCA
Paid-up capital
₹8 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
Last financials
Mar 2020
Balance sheet date

About Expergen Pharmaceuticals Private Limited

Data last updated:

Expergen Pharmaceuticals Private Limited is a private limited company based in Andheri East Mumbai, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 12 February 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2011PTC213351.

The company has an authorised share capital of ₹14 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Pooja Kumari and Rupa Sayiour.

Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Flat No. 204A Building 2 Lodnagiri Parsiwada Co – Operative Housing Society Sahar Road, Andheri East Mumbai, Maharashtra, India – 400069.

As per the financials filed for FY 2020, the company reported a revenue of ₹63,630, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹454 (net margin 0.7%) and EBITDA of ₹613 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 19% over five years.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company details

CIN U74120MH2011PTC213351
Registration Number 213351
Incorporation Date 12 February 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Non-Compliant

Contact details

Expergen Pharmaceuticals Private Limited's registered office is in Andheri East Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No. 204A Building 2 Lodnagiri Parsiwada Co – Operative Housing Society Sahar Road, Andheri East Mumbai, Maharashtra, India – 400069
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Expergen Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Expergen Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Expergen Pharmaceuticals Private Limited

FY 2020 filings available

Expergen Pharmaceuticals Private Limited reported revenue of ₹63,630 (up 10% YoY) for FY 2020.

Revenue · FY 2020
₹63,630 ▲ 10%
Net profit · FY 2020
₹454 margin 0.7%
EBITDA · FY 2020
₹613 margin 1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 31%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 33%
3 years · compounded
▼ 10%
5 years · compounded
▼ 32%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 10% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹613
Profit Before Tax
Tax Expense
Net Profit (PAT)₹454
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin1%
Net Profit Margin0.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Expergen Pharmaceuticals Private Limited, buy the company report.

Board of directors of Expergen Pharmaceuticals Private Limited

Expergen Pharmaceuticals has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pooja KumariDirector13 May 20242 Years 5 MonthsCurrent
Rupa SayiourDirector01 Apr 201313 Years 6 MonthsCurrent

Auditor

Expergen Pharmaceuticals Private Limited is audited by JHUMURKUMARMUKHOPADHYAY for the financial year 2017.

Auditor firmFinancial yearFirm registration number
JHUMURKUMARMUKHOPADHYAYFY 2017055993

Shareholding

The shareholding of Expergen Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Expergen Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Expergen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Expergen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Expergen Pharmaceuticals Private Limited has 9 board changes on record since 2011: 2 appointments and 7 cessations. The latest: Vijay Lahoti ceased to be Director on 15 May 2024.

Ceased
Vijay Lahoti ceased to be Director.
Appointed
Pooja Kumari was appointed as Director.
AGM
Expergen Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Filing
Expergen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai I.
Ceased
Rohit Agarwal ceased to be Director.
Ceased
Raj Kumar Singh ceased to be Director.
Appointed
Rupa Sayiour was appointed as Director.
Ceased
Dilip Pawar ceased to be Director.
Ceased
Namita Jitesh Agrawal ceased to be Director.
Ceased
Paul Meng ceased to be Director.
Ceased
Nital Kanubhai Patel ceased to be Director.
Incorporation
12 Feb 2011
Expergen Pharmaceuticals Private Limited was registered on 12 Feb 2011 with Roc Mumbai I & aged 15 years 8 months as per MCA records.

Frequently asked questions

Expergen Pharmaceuticals is an active private limited company based in Andheri East Mumbai, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 12 February 2011 (15+ years old) and is registered under CIN U74120MH2011PTC213351.

Expergen Pharmaceuticals has 2 current directors:

The latest financial statements of Expergen Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Expergen Pharmaceuticals is U74120MH2011PTC213351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Expergen Pharmaceuticals was incorporated on 12 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

Vijay Lahoti ceased to be Director on 15 May 2024. Pooja Kumari was appointed as Director on 13 May 2024. Rohit Agarwal ceased to be Director on 02 Jul 2014. Expergen Pharmaceuticals has 9 board changes on record in total.

The registered office of Expergen Pharmaceuticals is at Flat No. 204A Building 2 Lodnagiri Parsiwada Co – Operative Housing Society Sahar Road, Andheri East Mumbai, Maharashtra, India – 400069.

Expergen Pharmaceuticals operates in the trading industry, in the other wholesale segment.

The compliance status of Expergen Pharmaceuticals is active non-compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.

Expergen Pharmaceuticals can be reached at its registered office: Flat No. 204A Building 2 Lodnagiri Parsiwada Co – Operative Housing Society Sahar Road, Andheri East Mumbai, Maharashtra, India – 400069.